Evidence Report
Midwest CEPAC

PDF cover

This is not the most recent version of this material.
For an updated version, please see the relevant topic page.

Prostate Cancer: Evidence Report

Evidence report on anti-androgen drugs for high risk prostate cancer. This report will serve as the basis for discussion during a public meeting of Midwest CEPAC in September 2018.

View

View All Materials on this Topic or Go Back to View More Materials